45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,341
Insurances with rates
4
CPT / HCPCS codes
2,286
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2350 | OCREVUS 300MG/10ML VIAL | $42,000 | $42,000 | — | — | 0 |
| J9043 | JEVTANA INJ:60MG/1.5ML | $25,040 | $25,040 | — | — | 0 |
| J9042 | ADCETRIS (BRENTUXIMAB) 50MG INJ | $23,500 | $23,500 | — | — | 0 |
| J9022 | TECENTRIQ 1200MG/20ML SDV | $22,525 | $22,525 | — | — | 0 |
| J9144 | DARZALEX FASPRO 1800MG | $21,300 | $21,300 | — | — | 0 |
| J2997 | TPA (ACTIVASE) 100MG | $20,009 | $20,009 | — | — | 0 |
| J3380 | ENTYVIO 300MG INJ | $18,410 | $18,410 | — | — | 0 |
| J9228 | YERVOY 50MG/10ML | $17,168 | $17,168 | — | — | 0 |
| J3101 | TNKase 50MG VL | $17,000 | $17,000 | — | — | 0 |
| J2506 | NEULASTA 6MG INJ (PEGFILGRASTIN) | $14,606 | $14,606 | — | — | 0 |
| J9301 | GAZYVA 1000MG INJ | $14,087 | $14,087 | — | — | 0 |
| J9303 | VECTIBIX 400MG (20MG/ML) 20ML VIAL | $14,000 | $14,000 | — | — | 0 |
| J9306 | PERJETA (PERTUZUMAB) 420MG INJ | $14,000 | $14,000 | — | — | 0 |
| J9217 | LUPRON DEPOT 30MG | $13,132 | $13,132 | — | — | 0 |
| J9271 | KEYTRUDA 100MG INJ | $12,000 | $12,000 | — | — | 0 |
| J9017 | ARSENIC TRIOXIDE 10MG/10ML INJ | $11,940 | $11,940 | — | — | 0 |
| 33285 | INSERTION OF SUBCUTANEOUS CARDIAD RHYTH | $11,786 | $11,786 | — | — | 0 |
| J0491 | SAPHNELO 300MG INJ | $10,800 | $10,800 | — | — | 0 |
| 25545 | ORIF ULNAR SHAFT | $9,630 | $9,630 | — | — | 0 |
| J9173 | IMFINZI 500MG INJ | $9,000 | $9,000 | — | — | 0 |
| J2353 | SANDOSTATIN LAR DEP 30MG PFS | $8,565 | $8,565 | — | — | 0 |
| 25320 | CAPITOLUNATE FUSION | $8,315 | $8,315 | — | — | 0 |
| 49594 | VENTRAL HERNIA REPAIR 3-10CM & INCARC | $8,005 | $8,005 | — | — | 0 |
| J0896 | REBLOZYL 25MG INJ | $7,738 | $7,738 | — | — | 0 |
| J2182 | NUCALA 100MG INJ | $7,527 | $7,527 | — | — | 0 |
| J9035 | AVASTIN 400MG VIAL (BEVACIZUMAB) | $7,276 | $7,276 | — | — | 0 |
| Q5116 | TRAZIMERA (TRASTUZUMAB-QYYP) 420MG | $7,205 | $7,205 | — | — | 0 |
| J9354 | KADCYLA 100MG INJ | $6,683 | $6,683 | — | — | 0 |
| J9033 | TREANDA 100MG INJ | $6,296 | $6,296 | — | — | 0 |
| J9145 | DARZALEX 400MG/20ML | $6,100 | $6,100 | — | — | 0 |
| Q5107 | MVASI 400MG VIAL | $5,930 | $5,930 | — | — | 0 |
| J9358 | ENHERTU 100MG VIAL | $5,778 | $5,778 | — | — | 0 |
| 28615 | OPEN REDUCTION INTERNAL FIXATION RADIUS | $5,715 | $5,715 | — | — | 0 |
| 44160 | PARTIAL COLECTOMY | $5,573 | $5,573 | — | — | 0 |
| 17999 | REVISION OF CICATRIX | $5,390 | $5,390 | — | — | 0 |
| 49521 | INGUINAL HERNIA REPAIR - INCARCERATED | $5,331 | $5,331 | — | — | 0 |
| 49593 | VENTRAL HERNIA REPAIR 3-10CM | $5,157 | $5,157 | — | — | 0 |
| 49613 | REPAIR RECUR ANT ABDOM HERNIA LESS 3CM | $5,157 | $5,157 | — | — | 0 |
| 45110 | APR | $5,120 | $5,120 | — | — | 0 |
| J9285 | LARTRUVO 500MG/50ML VIAL | $5,101 | $5,101 | — | — | 0 |
| 50236 | NEPHRECTOMY WITH URETERECTOMY | $5,101 | $5,101 | — | — | 0 |
| 50785 | URETEROVESICOSTOMY-PSOAS HITCH | $5,060 | $5,060 | — | — | 0 |
| 38531 | BIOPSY OR EXCISION OF LYMPH NODE, OPEN | $5,004 | $5,004 | — | — | 0 |
| 72157 | MR THORACIC SPINE W/WO | $4,997 | $4,997 | — | — | 0 |
| 72158 | MR LUMBAR SPINE W/WO | $4,997 | $4,997 | — | — | 0 |
| 43620 | GASTRECTOMY (TOTAL) | $4,958 | $4,958 | — | — | 0 |
| 29880 | KNEE MENISCECTOMY MEDIAL & LATERAL | $4,842 | $4,842 | — | — | 0 |
| 49591 | ANTERIOR ABDOMINAL HERNIA REPAIR >3CM | $4,800 | $4,800 | — | — | 0 |
| 77049 | MR BREAST BILATATERAL W OR W AND W/O | $4,789 | $4,789 | — | — | 0 |
| 70546 | MRA HEAD W/WO | $4,789 | $4,789 | — | — | 0 |
Showing top 50 of 2,341 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.